T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Energy Recovery
ERII
$399M
| $312K | ﹤0.01% |
16,374
| – | – |
|
2552
Leslie's
LESL
$7.21M
| $312K | ﹤0.01% |
760
+80
| +12% | +$38.3K |
|
|
FRG
2553
DELISTED
Franchise Group, Inc.
FRG
| $312K | ﹤0.01% |
8,803
+106
| +1% | +$3.7K |
|
|
DNMR
2554
DELISTED
Danimer Scientific, Inc.
DNMR
| $311K | ﹤0.01% |
476
+43
| +10% | +$31.6K |
|
|
MCBC
2555
DELISTED
Macatawa Bank Corp
MCBC
| $311K | ﹤0.01% |
38,676
-10,440
| -21% | -$85.3K |
|
2556
WisdomTree
WT
$3.44B
| $309K | ﹤0.01% |
54,431
-200
| -0.4% | -$1.23K |
|
|
SPNE
2557
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $309K | ﹤0.01% |
19,618
+99
| +0.5% | +$1.69K |
|
2558
Anika Therapeutics
ANIK
$283M
| $307K | ﹤0.01% |
7,224
+27
| +0.4% | +$1.11K |
|
|
BCLI
2559
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $307K | ﹤0.01% |
6,200
| – | – |
|
|
SEI
2560
Solaris Energy Infrastructure
SEI
$3.94B
| $307K | ﹤0.01% |
36,807
| – | – |
|
2561
Camden National
CAC
$996M
| $306K | ﹤0.01% |
6,380
-6,954
| -52% | -$320K |
|
2562
Kinross Gold
KGC
$31.9B
| $306K | ﹤0.01% |
57,037
| – | – |
|
2563
National Healthcare
NHC
$3.44B
| $306K | ﹤0.01% |
4,378
| – | – |
|
2564
Inogen
INGN
$154M
| $305K | ﹤0.01% |
7,087
+130
| +2% | +$7.99K |
|
2565
ALX Oncology
ALXO
$268M
| $304K | ﹤0.01% |
4,110
+44
| +1% | +$2.93K |
|
2566
Seaboard Corp
SEB
$4.08B
| $303K | ﹤0.01% |
74
-3
| -4% | -$12.1K |
|
2567
Cadiz
CDZI
$295M
| $302K | ﹤0.01% |
42,856
-10,100
| -19% | -$124K |
|
2568
Global Industrial
GIC
$1.49B
| $302K | ﹤0.01% |
7,974
-89
| -1% | -$3.34K |
|
|
USAK
2569
DELISTED
USA Truck Inc
USAK
| $301K | ﹤0.01% |
19,700
+5,900
| +43% | +$85.4K |
|
|
CNR
2570
Core Natural Resources Inc
CNR
$4.64B
| $299K | ﹤0.01% |
11,510
+60
| +0.5% | +$1.32K |
|
2571
Pixelworks
PXLW
$45.7M
| $298K | ﹤0.01% |
5,200
| – | – |
|
|
MITT
2572
TPG Mortgage Investment Trust
MITT
$214M
| $297K | ﹤0.01% |
26,000
-7,100
| -21% | -$77.7K |
|
|
MAGN
2573
Magnera Corp
MAGN
$433M
| $297K | ﹤0.01% |
1,621
| – | – |
|
2574
Cars.com
CARS
$672M
| $296K | ﹤0.01% |
23,367
+200
| +0.9% | +$2.53K |
|
2575
IDT Corp
IDT
$1.67B
| $295K | ﹤0.01% |
7,030
+100
| +1% | +$4.67K |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.